Average Ratings 0 Ratings
Average Ratings 0 Ratings
Description
The Suite is designed to be both secure and scalable, featuring a contemporary and user-friendly interface that empowers scientists to have full control over the configuration of workflows for various techniques, modalities, and data types. The latest iteration, Signals VitroVivo 3.0, formerly known as Signal’s Screening, effectively converts raw data into practical insights, while Signals Inventa 3.0, previously called Signals Lead Discovery, serves as advanced analytics software that allows researchers to publish results effortlessly from diverse data sources. Additionally, it facilitates the capture of experimental data, oversees materials management, and streamlines collaboration workflows within an easy-to-navigate cloud-based electronic notebook. With adaptable visualizations and the ability to automate instrument data processing, the Suite enhances data quality and ensures reproducibility in research. It also provides a unified data management system for scientific outcomes, enriched with dynamic, interactive analytics. Furthermore, its extensibility allows for seamless integration with internal systems and partner processes, making it an invaluable tool for scientific discovery and innovation.
Description
By leveraging visual analytics through TIBCO Spotfire®, PerkinElmer Signals Translational offers a comprehensive suite of tools designed to harmonize, manage, search, aggregate, and analyze extensive datasets consistently for translational research, all while ensuring scalability. This platform, driven by TIBCO Spotfire®, supports precision medicine initiatives by providing an unparalleled solution for biomarker discovery and patient stratification. The Linear Mixed Effect App (LME) within Signals Translational empowers researchers to evaluate the influence of various factors on specific phenotypes, allowing for adjustments related to random variables during analysis. Furthermore, it enables the identification of genes significantly affecting cancer stage progression, irrespective of patient origins. Notably, the LME models excel at addressing issues such as missing values and outliers, making them a robust choice for discovering potential biomarkers. Consequently, the integration of these advanced analytics tools enhances the efficacy of translational research in identifying key biomarkers that can lead to more personalized treatment approaches.
API Access
Has API
API Access
Has API
Integrations
Signals Inventa
Signals Notebook
Signals Research Suite
Signals Translational
Signals VitroVivo
Integrations
Signals Inventa
Signals Notebook
Signals Research Suite
Signals Translational
Signals VitroVivo
Pricing Details
No price information available.
Free Trial
Free Version
Pricing Details
No price information available.
Free Trial
Free Version
Deployment
Web-Based
On-Premises
iPhone App
iPad App
Android App
Windows
Mac
Linux
Chromebook
Deployment
Web-Based
On-Premises
iPhone App
iPad App
Android App
Windows
Mac
Linux
Chromebook
Customer Support
Business Hours
Live Rep (24/7)
Online Support
Customer Support
Business Hours
Live Rep (24/7)
Online Support
Types of Training
Training Docs
Webinars
Live Training (Online)
In Person
Types of Training
Training Docs
Webinars
Live Training (Online)
In Person
Vendor Details
Company Name
PerkinElmer Informatics
Founded
1937
Country
United States
Website
perkinelmerinformatics.com/products/research/signals-research-suite/
Vendor Details
Company Name
PerkinElmer
Founded
1937
Country
United States
Website
perkinelmerinformatics.com/products/clinical-translational/signals-translational/
Product Features
Scientific Data Management System (SDMS)
Analytics
Artificial Intelligence (AI)
Audit
Centralized Data Repository
Collaboration
Compliance
Data Security
ELN Integration
LIMS Integration
Workflows